Products Categories
| CAS No.: | 141-53-7 |
|---|---|
| Name: | Sodium formate |
| Article Data: | 292 |
| Cas Database | |
| Molecular Structure: | |
|
|
|
| Formula: | CHNaO2 |
| Molecular Weight: | 68.0075 |
| Synonyms: | Salachlor;Sodium formate, refined;Formic acid, sodium salt;Sodium Formate(reagent grade);Sodium formate 95% & 97%;sodium formate 95% & 92%;Sodium formate 95%;Sodium Formate 96%;Sodium Formate 90%-98%;Leather, industrial special sodium formate;sodium formate 93% 95% supply; |
| EINECS: | 205-488-0 |
| Density: | 1.16 g/mL at 20 °C |
| Melting Point: | 259-262 °C(lit.) |
| Boiling Point: | 100.6 °C at 760 mmHg |
| Flash Point: | 29.9 °C |
| Solubility: | soluble in water |
| Appearance: | white crystals |
| Hazard Symbols: |
 Xi
|
| Risk Codes: | 36/37/38 |
| Safety: | 26-37/39-36 |
| PSA: | 40.13000 |
| LogP: | -0.99800 |
- 14154-09-7Phosphoric acid,manganese(2+) salt (2:3) (7CI,8CI,9CI)
- 141543-63-71-(5-Isoquinolinesulfonyl)piperazine Hydrochloride
- 14154-42-8Aluminum,chloro[29H,31H-phthalocyaninato(2-)-kN29,kN30,kN31,kN32]-, (SP-5-12)-
- 141556-45-81H-Imidazolium,1,3-bis(2,4,6-trimethylphenyl)-, chloride (1:1)
- 141563-06-61H-Imidazole-4-carbonitrile,1,5-diamino-
- 141567-53-54-Oxazolemethanol,2-methyl-
- 14156-84-41-(2-(N-Propylcyclohexylamino)ethyl)guanidine sulfate hydrate
- 141-57-1Silane,trichloropropyl-
- 1415-73-29(10H)-Anthracenone,10-b-D-glucopyranosyl-1,8-dihydroxy-3-(hydroxymethyl)-, (10S)-
- 141573-95-71H-Pyrazole-4-carboxylicacid, 3-(difluoromethyl)-1-methyl-, ethyl ester
- 50-00-0
formaldehyd
- 64-18-6
formic acid
- 75-07-0
acetaldehyde
A
- 115-77-5
Pentaerythritol
B
- 126-58-9
Dipentaerythritol
C
- 141-53-7
sodium formate
| Conditions | Yield |
|---|---|
| Stage #1: formaldehyd; acetaldehyde With sodium hydroxide at 45 - 65℃; under 1500.15 Torr; for 1.38333h; Inert atmosphere; Stage #2: formic acid pH=6; Product distribution / selectivity; | A 87.4% B 5% C 99.7% |
| Conditions | Yield |
|---|---|
| With sodium amalgam In not given Kinetics; High Pressure; in 1 M HCOONa-solution satd. with NaHCO3, CO2-pressure 15 kg/cm2 and at 0-55°C; | 99% |
| With sodium amalgam In water circulating CO2 and react. soln. at ambient temp., normal or raised pressure, pH 4.4-5.0;; | 91% |
| With sodium amalgam In not given Kinetics; in 1 M HCOONa-solution satd. with NaHCO3, CO2-pressure 1 kg/cm2 and at 0-55°C; | 70% |
- 141-53-7
sodium formate
| Conditions | Yield |
|---|---|
| With sodium nitrite In water at 90℃; under 760.051 Torr; for 6h; Reagent/catalyst; Concentration; Temperature; | 98.98% |
| Conditions | Yield |
|---|---|
| With carbon monoxide In water heating NaOH soln. with pressure 20 atm;; | 96.1% |
| With carbon monoxide In neat (no solvent) CO (6-7 atm.) is passed over finely powdered NaOH (eventually a mixture of NaOH and CaO) at 150-170°C;; | > 99 |
| With carbon monoxide In water |
- 1886-34-6
2-methyl-4-amino-5-formylaminomethylpyrimidine
A
- 95-02-3
5-(aminomethyl)-2-methylpyrimidin-4-amine
B
- 141-53-7
sodium formate
| Conditions | Yield |
|---|---|
| With sodium hydroxide; water In methanol at 66.84 - 75.84℃; for 4.5h; Product distribution / selectivity; | A 95.9% B 56.3% |
| With sodium hydroxide; water In 1,2-dimethoxyethane at 80℃; for 4h; Product distribution / selectivity; | A 94.2% B 91.9% |
| With sodium hydroxide; water In isopropyl alcohol at 80 - 85℃; for 3.5 - 5.5h; Product distribution / selectivity; | A 93.2% B 72.5% |
B
- 141-53-7
sodium formate
| Conditions | Yield |
|---|---|
| With sodium hydroxide In dimethyl sulfoxide at 100℃; for 12h; | A 95% B 61% |
| Conditions | Yield |
|---|---|
| With tetrasodium phenylporphyrintetrasulphonatoferrate(III); oxygen; sodium hydroxide In water at 150℃; under 15001.5 Torr; for 3h; Autoclave; | 94.7% |
| Conditions | Yield |
|---|---|
| With (bis[(2-diisopropylphosphino)ethyl]amine)Mn(CO)2Br; sodium hydroxide In 5,5-dimethyl-1,3-cyclohexadiene at 145℃; for 16h; Catalytic behavior; Reagent/catalyst; Solvent; Temperature; Schlenk technique; Inert atmosphere; | A 93% B n/a |
| Conditions | Yield |
|---|---|
| With sodium hydroxide In dimethyl sulfoxide (Rh(cod)Cl)2 and phosphine ligand are dissolved in DMSO under N2 and Et3N is added, mixt. is stirred for 20 min and transferred to an autoclave, which is purged and pressurised with CO2 (20 atm) and then with H2 (40 atm), after 18 h aq. NaOH is added; filtn. (catalyst), water and Et3O are removed from the filtrate in vac., filtn., washing (Et2O); amt. of formic acid by NMR; | 91% |
| With water; palladium In not given Electrolysis; high pressure;; poor yield;; | |
| With H2O | |
| With Mo(NO)(CO)(N(CH2CH2PiPr2)2); sodium hexamethyldisilazane In tetrahydrofuran at 140℃; under 75007.5 Torr; for 15h; Reagent/catalyst; Time; Inert atmosphere; Schlenk technique; Glovebox; Autoclave; High pressure; | 4 %Spectr. |
| Conditions | Yield |
|---|---|
| With sodium hydroxide; tetraethylammonium iodide; triphenylphosphine; bis(benzonitrile)palladium(II) dichloride In water; m-xylene at 85 - 90℃; for 14h; Product distribution; influence of various PTC; effect of molar ratio; | A 90% B 9.3% |
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
- 7631-86-9Silicon dioxide
- 302-79-4Tretinoin
- 77-92-9Citric acid
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
What can I do for you?
Get Best Price
Specification
The Sodium formate, with the CAS registry number 141-53-7,is also known as Thionyl dichloride. It belongs to the product categories of Salachlor; Formic acid sodium salt.This chemical's molecular formula is CHNaO2 and molecular weight is 68.01. What's more,Its systematic name is Sodium formate.It is white crystals,which is stable,incompatible with strong oxidizing agents,strong acids,protect from moisture.Its storage temperature is 2-8°C.The Sodium formate is irritating to eyes, respiratory system and skin.When you use it ,wear suitable protective clothing, gloves and eye/face protection.In case of contact with eyes, rinse immediately with plenty of water and seek medical advice .
Physical properties about Sodium formate are:
(1)ACD/LogP: -0.54; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): -2.30; (4)ACD/LogD (pH 7.4): -3.94; (5)ACD/BCF (pH 5.5): 1.00; (6)ACD/BCF (pH 7.4): 1.00; (7)ACD/KOC (pH 5.5): 1.00; (8)ACD/KOC (pH 7.4): 1.00; (9)#H bond acceptors: 2; (10)#H bond donors: 1; (11)#Freely Rotating Bonds: 0; (12)Flash Point: 29.9 °C; (13)Enthalpy of Vaporization: 22.69 kJ/mol; (14)Boiling Point: 100.6 °C at 760 mmHg; (15)Vapour Pressure: 36.5 mmHg at 25°C.
You can still convert the following datas into molecular structure:
(1)SMILES:[Na+].[O-]C=O;
(2)Std. InChI:InChI=1S/CH2O2.Na/c2-1-3;/h1H,(H,2,3);/q;+1/p-1;
(3)Std. InChIKey:HLBBKKJFGFRGMU-UHFFFAOYSA-M.
Production of Sodium formate:
Reacting chloroform with an alcoholic solution of sodium hydroxide produces sodium formate; neutralizeing formatic acid with sodium carbonate also produces Sodium formate. The formular is as following:
CHCl3 + 4NaOH → HCOONa + 3NaCl + 2H2O
by reacting sodium hydroxide with chloral hydrate:
2HCl3(OH)2 + NaOH → CHCl3 + HCOONa + H2O
The latter method is better than the former, since the low aqueous solubility of CHCl3 makes it easier to separate out from the sodium formate solution than the soluble NaCl would be by fractional crystallization.
The commercial way to produce sodium formate is to bsorbing carbon monoxide under pressure in solid sodium hydroxide at 160 °C, showing below:
CO + NaOH → HCOONa
The toxicity data of Sodium formate as follows:
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| cat | LDLo | subcutaneous | 1140mg/kg (1140mg/kg) | BEHAVIORAL: SLEEP BEHAVIORAL: MUSCLE WEAKNESS BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 21, Pg. 119, 1886. |
| dog | LDLo | intravenous | 3gm/kg (3000mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 16, Pg. 463, 1921. | |
| dog | LDLo | oral | 4gm/kg (4000mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 16, Pg. 463, 1921. | |
| mouse | LD50 | intravenous | 807mg/kg (807mg/kg) | Zeitschrift fuer Ernaehrungswissenschaft. Vol. 9, Pg. 332, 1969. | |
| mouse | LD50 | oral | 11200mg/kg (11200mg/kg) | Zeitschrift fuer Ernaehrungswissenschaft. Vol. 9, Pg. 332, 1969. | |
| mouse | LD50 | unreported | 2500mg/kg (2500mg/kg) | British Journal of Cancer. Vol. 6, Pg. 160, 1952. | |
| rabbit | LDLo | intravenous | 1250mg/kg (1250mg/kg) | KIDNEY, URETER, AND BLADDER: URINE VOLUME INCREASED SENSE ORGANS AND SPECIAL SENSES: MIOSIS (PUPILLARY CONSTRICTION): EYE AUTONOMIC NERVOUS SYSTEM: OTHER (DIRECT) PARASYMPATHOMIMETIC | Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 21, Pg. 119, 1886. |